65,437 trials
Cerebral Amyloid Angiopathy
Primary: Change From Baseline to Day 2 in Cerebrovascular Reactivity as Measured by the Slope (Amplitude Over Time to Peak) From Visual Task-evoked Functional Magnetic Resonance…
Rectal Cancer
Primary: Percentage of Pathologic Response Rate (pCR) With 95% Confidence Interval. — 26.6; 26.7 percentage of participants
Fissure in Ano · Pain
Primary: Change From Baseline in Pain Intensity at Days 14-18 — -40.4; -34.9 Units on a scale
Dengue · Dengue Fever · Dengue Hemorrhagic Fever
Primary: Percentage of Participants With Antibody Titer ≥ 10 1/Dil Against Each Dengue Virus Serotype Before and After Each Vaccination With Either Tetravalent Dengue Vaccine or…
Metastatic Breast Cancer
Primary: Objective Response Rate (ORR) — 30.8; 31.0; 55.6 percentage of participants
Acne Vulgaris
Primary: Percent Changes From Baseline in Total Lesion Counts — 58.3; 65.9; 25.5 percent change
Acne Vulgaris
Primary: Percent Changes From Baseline in Total Lesion Counts — 68.6; 82.7; 81.6 percent change
Diabetes Mellitus, Type 2
Primary: Mean Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 24 — -0.82 percentage
Gout
Primary: Percentage of Participants With Serum Urate <5.0 mg/dL at Month 3 — 0.3; 15.7; 25.9; 42.6 percentage of participants — p=<0.001
Breast Cancer
Primary: Disease-free Survival (DFS) Rate at 2 Years in TOP2A-amplified and in TOP2A-nonamplified HER2+ ESBC Patients Treated With TC+H. — 0.978; 0.979 probability of…
B-Cell Chronic Lymphocytic Leukemia
Primary: Infection Rate — 31.4; 36.5 percentage of participants
Juvenile Idiopathic Arthritis
Primary: Number of Participants With Any Adverse Events and Any Serious Adverse Events — 7; 0 participants
Normal Healthy Subjects With No Known Ocular Diseases · Glaucomatous Eyes · Eyes With Retinal Diseases
Primary: Optic Disc Measurements (Optic Disc Size) — 0.197; 0.097; 0.201 Mircrons squared
Type 1 Diabetes · Type 2 Diabetes
Primary: Enlite 3 Sensor Accuracy Mean Absolute Relative Difference (MARD) — 10.55; 10.35 percentage
Complications; Arthroplasty · Knee Injuries
Primary: Opioid Consumption (mg morEq) — 48; 60 Morphine Equivalents